BUPRENORPHINE HYDROCHLORIDE

BUPRENORPHINE HYDROCHLORIDE was reported 24312 times

BUPRENORPHINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHESUS INCOMPATIBILITY 38 0.3140
1 FOETAL NON-STRESS TEST ABNORMAL 12 0.2000
2 HYPOCHOLESTEROLAEMIA 60 0.1700
3 LIVING ALONE 4 0.1333
4 MENINGITIS NEONATAL 6 0.1091
5 ORAL ADMINISTRATION COMPLICATION 71 0.0763
6 OVERLAP SYNDROME 42 0.0600
7 LUPUS VULGARIS 72 0.0571
8 HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL 3 0.0536
9 DEPENDENCE 2858 0.0521
10 RETINITIS 69 0.0399
11 AMAUROSIS FUGAX 42 0.0390
12 MANUFACTURING PRODUCTION ISSUE 4 0.0385
13 MULTIPLE CARDIAC DEFECTS 4 0.0331
14 PRODUCT SOLUBILITY ABNORMAL 162 0.0321
15 CERVIX HAEMORRHAGE UTERINE 6 0.0312
16 DISLOCATION OF VERTEBRA 67 0.0293
17 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 4 0.0276
18 LARYNGOMALACIA 9 0.0269
19 JAUNDICE NEONATAL 49 0.0259
20 VITAMIN A DECREASED 4 0.0258
21 BREECH PRESENTATION 30 0.0238
22 DIARRHOEA NEONATAL 3 0.0236
23 PERIPHERAL VENOUS DISEASE 96 0.0235
24 GROWTH DISORDER 6 0.0222
25 BENIGN BONE NEOPLASM 4 0.0191
26 DRUG WITHDRAWAL SYNDROME NEONATAL 271 0.0183
27 BLEPHAROSPASM 114 0.0181
28 DECREASED GAIT VELOCITY 3 0.0179
29 DEEP VEIN THROMBOSIS POSTOPERATIVE 34 0.0170
30 SPEECH DISORDER DEVELOPMENTAL 45 0.0157
31 EXPOSURE VIA BREAST MILK 62 0.0156
32 INFUSION SITE REACTION 44 0.0147
33 AUTOINFLAMMATORY DISEASE 3 0.0142
34 FOETAL DISTRESS SYNDROME 30 0.0141
35 BREAKTHROUGH PAIN 32 0.0138
36 SWOLLEN JOINT COUNT INCREASED 44 0.0138
37 DRUG SCREEN NEGATIVE 24 0.0136
38 X-RAY ABNORMAL 24 0.0134
39 BREAST CANCER STAGE III 84 0.0130
40 FACET JOINT SYNDROME 41 0.0126
41 RHEUMATIC FEVER 56 0.0126
42 LEARNING DISORDER 30 0.0124
43 NEONATAL ASPIRATION 4 0.0122
44 SECONDARY HYPOGONADISM 4 0.0121
45 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 86 0.0120
46 HOMELESS 5 0.0112
47 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 6 0.0111
48 BONE INFARCTION 5 0.0110
49 PRODUCT PHYSICAL CONSISTENCY ISSUE 60 0.0108
50 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6 0.0107
51 PRODUCT PACKAGING DIFFICULT TO OPEN 27 0.0103
52 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 21 0.0101
53 DENTAL CARIES 109 0.0098
54 ATTENTION DEFICIT HYPERACTIVITY DISORDER 41 0.0097
55 FOLLICULITIS 95 0.0091
56 THEFT 6 0.0090
57 TREMOR NEONATAL 4 0.0090
58 C-REACTIVE PROTEIN 8 0.0086
59 BONE EROSION 30 0.0085
60 BACK INJURY 91 0.0084
61 LIVE BIRTH 69 0.0082
62 LIVIDITY 3 0.0082
63 CEREBRAL VASOCONSTRICTION 6 0.0081
64 RED BLOOD CELL SEDIMENTATION RATE INCREASED 89 0.0080
65 FEMALE STERILISATION 4 0.0078
66 EXOSTOSIS 71 0.0078
67 PRODUCT ADHESION ISSUE 276 0.0077
68 ONYCHOMADESIS 32 0.0076
69 JOINT RANGE OF MOTION DECREASED 102 0.0076
70 GINGIVAL DISCOMFORT 5 0.0076
71 PALMOPLANTAR PUSTULOSIS 4 0.0076
72 NEONATAL RESPIRATORY DISTRESS 7 0.0074
73 INFLAMMATORY PAIN 5 0.0074
74 TOOTH EROSION 9 0.0073
75 RHEUMATOID FACTOR POSITIVE 41 0.0071
76 BURSITIS 83 0.0068
77 ILL-DEFINED DISORDER 414 0.0068
78 OVERDOSE 1452 0.0067
79 DRUG DETOXIFICATION 6 0.0067
80 CHOLESTASIS OF PREGNANCY 3 0.0065
81 THERAPEUTIC RESPONSE INCREASED 6 0.0064
82 INTENTIONAL MISUSE 12 0.0063
83 PORPHYRIA ACUTE 9 0.0063
84 LIP DRY 56 0.0062
85 POST-TRAUMATIC STRESS DISORDER 41 0.0061
86 SUBSTANCE USE DISORDER 19 0.0060
87 INFUSION SITE ABSCESS 3 0.0060
88 WITHDRAWAL SYNDROME 247 0.0059
89 HAEMORRHAGIC STROKE 45 0.0058
90 SUBSTANCE ABUSE 46 0.0056
91 SELECTIVE EATING DISORDER 5 0.0055
92 MUSCLE INJURY 45 0.0054
93 PREMATURE DELIVERY 86 0.0054
94 DEMENTIA WITH LEWY BODIES 6 0.0054
95 DUODENAL ULCER PERFORATION 40 0.0054
96 SERONEGATIVE ARTHRITIS 6 0.0052
97 HYPERBILIRUBINAEMIA NEONATAL 3 0.0052
98 SYNOVITIS 93 0.0052
99 TASTE DISORDER 103 0.0051
100 PERICARDITIS 84 0.0050
101 IRRITABLE BOWEL SYNDROME 107 0.0050
102 HYPERCHOLESTEROLAEMIA 48 0.0050
103 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 85 0.0050
104 BREAST CANCER STAGE II 41 0.0049
105 DEVELOPMENTAL DELAY 44 0.0049
106 OESOPHAGEAL ACHALASIA 3 0.0047
107 PROTEIN TOTAL ABNORMAL 6 0.0046
108 INFUSION SITE MASS 5 0.0046
109 ORAL MUCOSAL ERUPTION 7 0.0046
110 PREMATURE SEPARATION OF PLACENTA 7 0.0045
111 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 3 0.0044
112 FEELING OF RELAXATION 3 0.0044
113 CYTOKINE STORM 3 0.0044
114 GLOSSODYNIA 96 0.0043
115 FOETAL EXPOSURE TIMING UNSPECIFIED 3 0.0042
116 CEREBELLAR ATAXIA 4 0.0042
117 AGITATION NEONATAL 4 0.0042
118 DENTAL RESTORATION FAILURE 3 0.0042
119 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
120 OCULAR DISCOMFORT 45 0.0040
121 DROWNING 4 0.0040
122 AUTONOMIC NEUROPATHY 4 0.0039
123 WOUND INFECTION 43 0.0039
124 DRUG USE DISORDER 33 0.0039
125 NOCTURNAL DYSPNOEA 5 0.0039
126 POLYHYDRAMNIOS 4 0.0039
127 HELICOBACTER INFECTION 39 0.0038
128 EMBOLIA CUTIS MEDICAMENTOSA 3 0.0038
129 FOETAL EXPOSURE DURING PREGNANCY 306 0.0038
130 GRIP STRENGTH DECREASED 33 0.0037
131 C-REACTIVE PROTEIN ABNORMAL 24 0.0037
132 AUTOIMMUNE DISORDER 35 0.0036
133 TONSILLAR HYPERTROPHY 6 0.0036
134 URINARY TRACT DISORDER 16 0.0035
135 ULCER HAEMORRHAGE 24 0.0035
136 INFUSION SITE DISCHARGE 6 0.0034
137 TOOTH DISCOLOURATION 10 0.0034
138 WOUND 95 0.0034
139 INCORRECT PRODUCT FORMULATION ADMINISTERED 3 0.0034
140 PREMATURE BABY 99 0.0033
141 MASTICATION DISORDER 10 0.0033
142 LYMPHOCYTOSIS 7 0.0032
143 MIOSIS 26 0.0032
144 DRUG TOLERANCE DECREASED 9 0.0032
145 HYPOTONIA NEONATAL 5 0.0032
146 PRODUCT COMMUNICATION ISSUE 28 0.0032
147 HEPATIC CONGESTION 3 0.0032
148 HYPERAESTHESIA TEETH 4 0.0032
149 DRUG TOLERANCE 16 0.0032
150 ARNOLD-CHIARI MALFORMATION 3 0.0031
151 CHOLESTATIC LIVER INJURY 7 0.0031
152 NAIL DISORDER 27 0.0031
153 TOOTH FRACTURE 34 0.0031
154 IMPAIRED HEALING 101 0.0031
155 MATERNAL EXPOSURE DURING PREGNANCY 273 0.0031
156 PEMPHIGUS 37 0.0030
157 DEAFNESS BILATERAL 5 0.0029
158 ACCIDENTAL POISONING 4 0.0029
159 DRUG DIVERSION 18 0.0029
160 POLYCYTHAEMIA 6 0.0029
161 HAND DEFORMITY 37 0.0028
162 INABILITY TO AFFORD MEDICATION 28 0.0028
163 PERSECUTORY DELUSION 7 0.0028
164 NIGHT SWEATS 89 0.0028
165 LUPUS-LIKE SYNDROME 24 0.0026
166 PRODUCT PACKAGING ISSUE 25 0.0026
167 GINGIVAL RECESSION 5 0.0026
168 CONTRAINDICATED PRODUCT ADMINISTERED 78 0.0026
169 JOINT DESTRUCTION 4 0.0026
170 HEAD DISCOMFORT 45 0.0025
171 TOOTH INJURY 11 0.0025
172 ONYCHOMYCOSIS 11 0.0025
173 C-REACTIVE PROTEIN INCREASED 91 0.0025
174 INCORRECT DOSE ADMINISTERED BY PRODUCT 4 0.0025
175 ACCIDENTAL OVERDOSE 90 0.0025
176 ALTERED STATE OF CONSCIOUSNESS 53 0.0024
177 ASPIRATION 26 0.0024
178 EAR SWELLING 5 0.0024
179 ENDOCARDITIS 12 0.0023
180 APGAR SCORE LOW 3 0.0023
181 TOOTH LOSS 48 0.0023
182 CAESAREAN SECTION 26 0.0022
183 PRODUCT SIZE ISSUE 12 0.0022
184 PRODUCT LABEL CONFUSION 13 0.0022
185 GAMBLING DISORDER 6 0.0022
186 FREQUENT BOWEL MOVEMENTS 60 0.0022
187 PSORIATIC ARTHROPATHY 90 0.0022
188 HEPATIC CIRRHOSIS 41 0.0022
189 AUTISM SPECTRUM DISORDER 12 0.0022
190 LOOSE TOOTH 7 0.0022
191 ACCIDENTAL DEATH 4 0.0022
192 MAST CELL ACTIVATION SYNDROME 3 0.0021
193 PRESCRIBED OVERDOSE 41 0.0021
194 TRANSFUSION 22 0.0021
195 GASTROOESOPHAGEAL REFLUX DISEASE 169 0.0021
196 MATERNAL DRUGS AFFECTING FOETUS 16 0.0021
197 ABDOMINAL WALL HAEMATOMA 4 0.0020
198 RESPIRATORY DEPRESSION 25 0.0020
199 COCCYDYNIA 3 0.0020
200 LIVER INJURY 50 0.0020
201 BEHAVIOUR DISORDER 11 0.0020
202 PRODUCT PHYSICAL ISSUE 41 0.0020
203 DISABILITY 40 0.0020
204 SCIATICA 32 0.0020
205 BLOOD CHOLESTEROL INCREASED 93 0.0020
206 PRODUCT TASTE ABNORMAL 27 0.0020
207 LOSS OF EMPLOYMENT 6 0.0020
208 EYE INJURY 6 0.0020
209 MUSCLE CONTRACTURE 4 0.0020
210 EPILEPSY 60 0.0020
211 OSTEOLYSIS 4 0.0020
212 PYODERMA GANGRENOSUM 7 0.0019
213 ORAL MUCOSAL ERYTHEMA 3 0.0019
214 FIBROMYALGIA 47 0.0019
215 PRESCRIBED UNDERDOSE 38 0.0019
216 DRUG ABUSE 158 0.0019
217 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 32 0.0019
218 PRODUCT PRESCRIBING ISSUE 41 0.0019
219 LUNG DISORDER 92 0.0019
220 THERAPEUTIC RESPONSE DECREASED 113 0.0019
221 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
222 GENERALISED OEDEMA 23 0.0019
223 HAEMATEMESIS 47 0.0019
224 BRADYPNOEA 5 0.0019
225 TOOTH DISORDER 41 0.0018
226 NORMAL NEWBORN 10 0.0018
227 INFUSION SITE HAEMORRHAGE 6 0.0018
228 GINGIVAL DISORDER 7 0.0018
229 OBESITY 29 0.0018
230 DRUG SCREEN FALSE POSITIVE 5 0.0018
231 GAIT INABILITY 60 0.0018
232 ELECTRIC SHOCK SENSATION 5 0.0018
233 RESPIRATORY SYMPTOM 5 0.0018
234 JOINT STIFFNESS 46 0.0018
235 PUSTULAR PSORIASIS 6 0.0017
236 TACHYPHRENIA 6 0.0017
237 STOMATITIS 105 0.0017
238 INFLAMMATION 89 0.0017
239 CARDIO-RESPIRATORY ARREST 72 0.0017
240 INFUSION SITE INFECTION 4 0.0017
241 LOWER LIMB FRACTURE 33 0.0017
242 EMOTIONAL POVERTY 3 0.0017
243 HYPERAESTHESIA 14 0.0017
244 CONGENITAL ANOMALY 13 0.0017
245 MIXED LIVER INJURY 5 0.0017
246 BLISTER 93 0.0017
247 RASH VESICULAR 8 0.0017
248 OSTEOPOROSIS 68 0.0017
249 FINGER DEFORMITY 8 0.0016
250 INFUSION RELATED REACTION 108 0.0016
251 DENTAL CARE 3 0.0016
252 HYPERVOLAEMIA 8 0.0016
253 COMA 77 0.0016
254 INTERVERTEBRAL DISCITIS 3 0.0016
255 OSTEITIS 4 0.0016
256 MIGRAINE 150 0.0016
257 PULMONARY FIBROSIS 30 0.0016
258 ADRENAL DISORDER 3 0.0016
259 PRODUCT COLOUR ISSUE 8 0.0016
260 HEPATIC ENZYME INCREASED 106 0.0016
261 TOOTHACHE 28 0.0015
262 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 10 0.0015
263 ASCITES 45 0.0015
264 BICYTOPENIA 3 0.0015
265 MUSCULOSKELETAL PAIN 79 0.0015
266 DRY MOUTH 122 0.0015
267 YAWNING 4 0.0015
268 BRAIN INJURY 15 0.0015
269 ALCOHOL ABUSE 4 0.0015
270 PRODUCT ADMINISTRATION ERROR 30 0.0015
271 SPINAL FUSION SURGERY 6 0.0015
272 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
273 EYELID PAIN 3 0.0015
274 SYSTEMIC LUPUS ERYTHEMATOSUS 52 0.0015
275 LOGORRHOEA 5 0.0014
276 TONGUE DISCOMFORT 6 0.0014
277 APPLICATION SITE SWELLING 7 0.0014
278 EXPOSURE DURING PREGNANCY 87 0.0014
279 LIVER FUNCTION TEST INCREASED 30 0.0014
280 PRODUCT USE COMPLAINT 22 0.0014
281 OSTEOARTHRITIS 59 0.0014
282 MOUTH SWELLING 8 0.0014
283 BLINDNESS 55 0.0013
284 CARDIAC DYSFUNCTION 5 0.0013
285 ENDOPHTHALMITIS 8 0.0013
286 CRANIOCEREBRAL INJURY 4 0.0013
287 LEARNING DISABILITY 7 0.0013
288 RESPIRATORY DISORDER 39 0.0013
289 NECK SURGERY 3 0.0013
290 TALIPES 4 0.0013
291 DRUG WITHDRAWAL SYNDROME 113 0.0013
292 DEPRESSION 292 0.0013
293 POLYNEUROPATHY 15 0.0013
294 OBSTRUCTION 5 0.0013
295 TYPE 2 DIABETES MELLITUS 42 0.0012
296 PRODUCT QUALITY ISSUE 163 0.0012
297 ANXIETY DISORDER 4 0.0012
298 PLANTAR FASCIITIS 4 0.0012
299 SLEEP DISORDER 84 0.0012
300 HALLUCINATIONS, MIXED 5 0.0012
301 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
302 GENERAL PHYSICAL HEALTH DETERIORATION 134 0.0012
303 TOXICITY TO VARIOUS AGENTS 195 0.0012
304 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
305 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
306 EAR PAIN 22 0.0011
307 HAEMORRHAGIC DIATHESIS 4 0.0011
308 BLOOD SODIUM INCREASED 3 0.0011
309 FEELING HOT 68 0.0011
310 ASPHYXIA 9 0.0011
311 DRUG TOXICITY 15 0.0011
312 SPONDYLITIS 4 0.0011
313 APPLICATION SITE HAEMORRHAGE 3 0.0011
314 CAROTID ARTERY OCCLUSION 4 0.0011
315 THERAPEUTIC PRODUCT EFFECT DECREASED 49 0.0011
316 INJURY 76 0.0011
317 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
318 HEPATITIS C 13 0.0011
319 EUPHORIC MOOD 11 0.0011
320 DELIRIUM 37 0.0011
321 SNORING 4 0.0011
322 SKIN ABRASION 5 0.0011
323 SPINAL OPERATION 13 0.0011
324 POISONING DELIBERATE 10 0.0011
325 JOINT DISLOCATION 11 0.0010
326 PARAPLEGIA 3 0.0010
327 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
328 FAECES HARD 4 0.0010
329 ROAD TRAFFIC ACCIDENT 43 0.0010
330 LUMBAR SPINAL STENOSIS 3 0.0010
331 BLOOD TESTOSTERONE DECREASED 7 0.0010
332 NECK INJURY 3 0.0010
333 INTENTIONAL PRODUCT USE ISSUE 89 0.0010
334 MEMORY IMPAIRMENT 139 0.0010
335 LOW BIRTH WEIGHT BABY 8 0.0010
336 HYPERCAPNIA 3 0.0010
337 TRIGEMINAL NEURALGIA 4 0.0010
338 GALLBLADDER OPERATION 4 0.0010
339 ORAL CANDIDIASIS 13 0.0010
340 HOMICIDAL IDEATION 4 0.0010
341 DRUG ABUSER 6 0.0010
342 PRODUCT DISTRIBUTION ISSUE 9 0.0010
343 EYE PAIN 54 0.0010
344 PHOTOPHOBIA 18 0.0010
345 WEIGHT FLUCTUATION 10 0.0010
346 DRUG EFFECT INCREASED 3 0.0009
347 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
348 CEREBRAL DISORDER 7 0.0009
349 SHOULDER OPERATION 4 0.0009
350 ARTHROPATHY 52 0.0009
351 BIPOLAR DISORDER 10 0.0009
352 TOOTH INFECTION 12 0.0009
353 WALKING AID USER 6 0.0009
354 NEAR DEATH EXPERIENCE 3 0.0009
355 AMNESIA 59 0.0009
356 EXPOSURE DURING BREAST FEEDING 3 0.0009
357 GASTROINTESTINAL DISORDER 81 0.0009
358 FOOT DEFORMITY 10 0.0009
359 EAR INFECTION 24 0.0009
360 DELUSION 14 0.0009
361 OLIGOHYDRAMNIOS 3 0.0009
362 VISUAL IMPAIRMENT 111 0.0009
363 WHEEZING 53 0.0009
364 MULTIPLE ALLERGIES 7 0.0009
365 SUSPECTED OFF LABEL USE 4 0.0009
366 IMPAIRED DRIVING ABILITY 10 0.0009
367 GINGIVAL PAIN 7 0.0009
368 HEPATIC FIBROSIS 3 0.0009
369 BLOOD DISORDER 7 0.0009
370 SYNOVIAL CYST 4 0.0009
371 PRESYNCOPE 21 0.0009
372 RENAL FUNCTION TEST ABNORMAL 4 0.0009
373 ABDOMINAL PAIN UPPER 176 0.0009
374 JOINT SWELLING 103 0.0009
375 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
376 VAGINAL INFECTION 4 0.0008
377 GLOSSITIS 3 0.0008
378 SPINAL DISORDER 8 0.0008
379 PRE-ECLAMPSIA 4 0.0008
380 VISUAL FIELD DEFECT 6 0.0008
381 PERIPHERAL SWELLING 127 0.0008
382 FOETAL GROWTH RESTRICTION 5 0.0008
383 INGUINAL HERNIA 5 0.0008
384 BLOOD PHOSPHORUS DECREASED 3 0.0008
385 HYPOMANIA 3 0.0008
386 APPLICATION SITE BURN 4 0.0008
387 TACHYCARDIA 72 0.0008
388 LIGAMENT SPRAIN 8 0.0008
389 DIPLOPIA 21 0.0008
390 MOBILITY DECREASED 58 0.0008
391 GINGIVAL BLEEDING 11 0.0008
392 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 163 0.0008
393 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 57 0.0008
394 ASTHMA 90 0.0008
395 ERYSIPELAS 4 0.0008
396 INFUSION SITE SWELLING 5 0.0008
397 ABDOMINAL DISCOMFORT 133 0.0008
398 RHEUMATOID ARTHRITIS 90 0.0008
399 PARANASAL SINUS DISCOMFORT 3 0.0008
400 ECONOMIC PROBLEM 12 0.0008
401 SWELLING 74 0.0008
402 TOOTH ABSCESS 8 0.0008
403 COMMUNICATION DISORDER 3 0.0008
404 THERAPY NON-RESPONDER 35 0.0008
405 SKIN NECROSIS 4 0.0008
406 RESTLESS LEGS SYNDROME 14 0.0008
407 EPIGASTRIC DISCOMFORT 3 0.0008
408 BRAIN FOG 12 0.0008
409 ORAL PAIN 17 0.0008
410 DRUG SCREEN POSITIVE 6 0.0008
411 POLYARTHRITIS 4 0.0008
412 MUSCLE RIGIDITY 9 0.0008
413 NECK PAIN 42 0.0008
414 LIVER DISORDER 33 0.0007
415 GINGIVITIS 4 0.0007
416 OEDEMA 40 0.0007
417 ARTHRITIS BACTERIAL 3 0.0007
418 ECCHYMOSIS 5 0.0007
419 ANXIETY 206 0.0007
420 TOOTH EXTRACTION 9 0.0007
421 HYPOAESTHESIA 108 0.0007
422 PARAESTHESIA 112 0.0007
423 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
424 DRUG-INDUCED LIVER INJURY 22 0.0007
425 HAEMATURIA 24 0.0007
426 DYSPHAGIA 66 0.0007
427 INTENTIONAL UNDERDOSE 5 0.0007
428 DRUG INTOLERANCE 66 0.0007
429 SEXUAL DYSFUNCTION 8 0.0007
430 ORAL DISORDER 5 0.0007
431 SEROTONIN SYNDROME 13 0.0007
432 BACK DISORDER 11 0.0007
433 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
434 DISCOMFORT 41 0.0007
435 MYOSITIS 6 0.0007
436 LOSS OF LIBIDO 6 0.0007
437 GENERAL SYMPTOM 5 0.0007
438 IRON DEFICIENCY 3 0.0007
439 KNEE ARTHROPLASTY 14 0.0007
440 PRODUCT USE ISSUE 124 0.0007
441 ADRENAL INSUFFICIENCY 8 0.0007
442 NEURALGIA 16 0.0007
443 SEPSIS 73 0.0007
444 HIP ARTHROPLASTY 10 0.0007
445 ARTHRITIS INFECTIVE 3 0.0006
446 HYPOALBUMINAEMIA 5 0.0006
447 CARPAL TUNNEL SYNDROME 9 0.0006
448 INFUSION SITE EXTRAVASATION 4 0.0006
449 URINARY INCONTINENCE 19 0.0006
450 FEEDING DISORDER 13 0.0006
451 CONFUSIONAL STATE 103 0.0006
452 SEASONAL ALLERGY 9 0.0006
453 INSOMNIA 168 0.0006
454 MEDICATION RESIDUE PRESENT 3 0.0006
455 MALNUTRITION 7 0.0006
456 INFUSION SITE PAIN 8 0.0006
457 MUSCLE SPASMS 113 0.0006
458 TREATMENT FAILURE 51 0.0006
459 POST PROCEDURAL INFECTION 5 0.0006
460 COELIAC DISEASE 6 0.0006
461 MYOCARDITIS 7 0.0006
462 KNEE OPERATION 6 0.0006
463 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
464 DECREASED APPETITE 140 0.0006
465 INFUSION SITE ERYTHEMA 5 0.0006
466 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
467 IMPAIRED GASTRIC EMPTYING 8 0.0006
468 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
469 CACHEXIA 3 0.0006
470 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
471 INTENTIONAL PRODUCT MISUSE 51 0.0006
472 CHILLS 68 0.0006
473 EJECTION FRACTION DECREASED 9 0.0006
474 ORAL DISCOMFORT 8 0.0006
475 PSYCHOTIC DISORDER 17 0.0006
476 CARDIOMEGALY 7 0.0006
477 VOMITING 264 0.0006
478 HAEMARTHROSIS 5 0.0006
479 IMPAIRED QUALITY OF LIFE 8 0.0006
480 ANAL INCONTINENCE 5 0.0006
481 PHARYNGITIS STREPTOCOCCAL 6 0.0006
482 INFECTION 80 0.0006
483 LIMB INJURY 15 0.0006
484 MENTAL DISORDER 24 0.0006
485 SOMNOLENCE 111 0.0006
486 CONTUSION 53 0.0005
487 PREGNANCY 11 0.0005
488 FAECALOMA 3 0.0005
489 HEPATITIS 14 0.0005
490 SUICIDE ATTEMPT 33 0.0005
491 PAIN 330 0.0005
492 THINKING ABNORMAL 10 0.0005
493 DEATH 461 0.0005
494 FLANK PAIN 5 0.0005
495 ABORTION INDUCED 5 0.0005
496 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
497 PERIORBITAL SWELLING 3 0.0005
498 DYSPEPSIA 52 0.0005
499 ADVERSE REACTION 7 0.0005
500 DIZZINESS 263 0.0005
501 HYPERTONIA 3 0.0005
502 HYPERSOMNIA 15 0.0005
503 TINNITUS 24 0.0005
504 MOUTH ULCERATION 11 0.0005
505 MEDICATION ERROR 29 0.0005
506 PNEUMONIA ASPIRATION 13 0.0005
507 DISTURBANCE IN ATTENTION 28 0.0005
508 DIZZINESS POSTURAL 5 0.0005
509 PHARYNGEAL SWELLING 5 0.0005
510 DRUG DEPENDENCE 82 0.0005
511 KIDNEY INFECTION 10 0.0005
512 URINARY RETENTION 17 0.0005
513 PRODUCT PRESCRIBING ERROR 12 0.0005
514 ACCIDENT 6 0.0005
515 SALIVARY HYPERSECRETION 5 0.0005
516 LOCALISED INFECTION 12 0.0005
517 FRUSTRATION TOLERANCE DECREASED 4 0.0005
518 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
519 HYPOTHERMIA 5 0.0005
520 HEADACHE 309 0.0005
521 SHOCK HAEMORRHAGIC 4 0.0005
522 WEIGHT INCREASED 110 0.0005
523 INTENTIONAL DOSE OMISSION 14 0.0005
524 HALLUCINATION 37 0.0005
525 ANGINA PECTORIS 14 0.0005
526 ARTHRALGIA 203 0.0005
527 INITIAL INSOMNIA 5 0.0005
528 PRODUCT DOSE OMISSION ISSUE 142 0.0005
529 DISORIENTATION 19 0.0005
530 SINUSITIS 49 0.0005
531 POISONING 6 0.0005
532 MUSCULAR WEAKNESS 54 0.0005
533 BRAIN OEDEMA 6 0.0005
534 HEAD INJURY 15 0.0005
535 SLEEP APNOEA SYNDROME 9 0.0005
536 COGNITIVE DISORDER 22 0.0005
537 INADEQUATE ANALGESIA 4 0.0005
538 CIRCULATORY COLLAPSE 8 0.0005
539 HYPERHIDROSIS 60 0.0005
540 BLOOD MAGNESIUM DECREASED 4 0.0005
541 DECREASED ACTIVITY 5 0.0005
542 CONSTIPATION 101 0.0005
543 NIGHTMARE 16 0.0005
544 CARDIAC MURMUR 4 0.0005
545 HYSTERECTOMY 4 0.0005
546 OSTEOPENIA 7 0.0005
547 SKIN LACERATION 5 0.0005
548 BRADYPHRENIA 3 0.0005
549 SEDATION 12 0.0005
550 ASTHENIA 171 0.0005
551 MENTAL IMPAIRMENT 11 0.0005
552 NERVE INJURY 5 0.0004
553 MENINGITIS 3 0.0004
554 SKIN INFECTION 5 0.0004
555 CYANOSIS 7 0.0004
556 NAUSEA 352 0.0004
557 SINUS CONGESTION 6 0.0004
558 FALL 147 0.0004
559 PNEUMOTHORAX 7 0.0004
560 ULCER 7 0.0004
561 AGGRESSION 22 0.0004
562 RIB FRACTURE 9 0.0004
563 ABDOMINAL PAIN 101 0.0004
564 CONDITION AGGRAVATED 132 0.0004
565 LYMPHOEDEMA 3 0.0004
566 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
567 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
568 CONJUNCTIVITIS 8 0.0004
569 ERYTHEMA MULTIFORME 4 0.0004
570 VERTIGO 26 0.0004
571 APPLICATION SITE REACTION 3 0.0004
572 UNDERDOSE 31 0.0004
573 PAIN IN JAW 12 0.0004
574 COVID-19 PNEUMONIA 5 0.0004
575 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
576 ATAXIA 5 0.0004
577 FEELING JITTERY 8 0.0004
578 MYOCLONUS 5 0.0004
579 HYPOACUSIS 18 0.0004
580 URTICARIA 70 0.0004
581 DRUG INTERACTION 66 0.0004
582 HYPERTENSION 88 0.0004
583 SUICIDAL IDEATION 38 0.0004
584 HYPOKINESIA 6 0.0004
585 CHEST PAIN 76 0.0004
586 MOUTH HAEMORRHAGE 3 0.0004
587 AGITATION 30 0.0004
588 RENAL DISORDER 19 0.0004
589 THERAPY CHANGE 4 0.0004
590 SMALL INTESTINAL OBSTRUCTION 5 0.0004
591 BRONCHITIS 30 0.0004
592 FEELING DRUNK 3 0.0004
593 APPLICATION SITE IRRITATION 5 0.0004
594 KETOACIDOSIS 3 0.0004
595 DYSARTHRIA 15 0.0004
596 SEIZURE 46 0.0004
597 COLD SWEAT 7 0.0004
598 PROCEDURAL PAIN 11 0.0004
599 RECTAL HAEMORRHAGE 17 0.0004
600 FLUID RETENTION 20 0.0004
601 SLUGGISHNESS 4 0.0004
602 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
603 OXYGEN SATURATION DECREASED 22 0.0004
604 DRUG EFFECT DECREASED 21 0.0004
605 EAR DISCOMFORT 4 0.0004
606 FOOD ALLERGY 3 0.0004
607 HYPERSENSITIVITY 72 0.0004
608 CONCUSSION 3 0.0004
609 UNRESPONSIVE TO STIMULI 10 0.0004
610 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
611 BONE DISORDER 7 0.0004
612 TENDERNESS 4 0.0004
613 GAIT DISTURBANCE 73 0.0004
614 GASTRITIS 10 0.0004
615 ADVERSE EVENT 35 0.0004
616 PULMONARY CONGESTION 5 0.0004
617 HALLUCINATION, VISUAL 8 0.0004
618 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
619 PYREXIA 131 0.0004
620 PANCREATITIS 20 0.0004
621 BLOOD ALBUMIN DECREASED 3 0.0004
622 RESPIRATORY TRACT CONGESTION 6 0.0004
623 MUSCULOSKELETAL STIFFNESS 33 0.0004
624 ABSCESS 6 0.0004
625 PRODUCT USE IN UNAPPROVED INDICATION 93 0.0004
626 JOINT INJURY 8 0.0004
627 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
628 PRURITUS 143 0.0004
629 DIARRHOEA 240 0.0004
630 MYASTHENIA GRAVIS 3 0.0004
631 MUSCLE TIGHTNESS 6 0.0004
632 HYPOCALCAEMIA 7 0.0004
633 RASH 161 0.0004
634 HYPOXIA 13 0.0004
635 PRODUCT DISPENSING ERROR 8 0.0004
636 PRODUCT SUBSTITUTION ISSUE 21 0.0004
637 POST PROCEDURAL COMPLICATION 7 0.0004
638 APPLICATION SITE PAIN 8 0.0004
639 STEVENS-JOHNSON SYNDROME 8 0.0004
640 RHABDOMYOLYSIS 15 0.0004
641 PULMONARY OEDEMA 16 0.0004
642 TREMOR 59 0.0004
643 CANDIDA INFECTION 6 0.0004
644 RESTLESSNESS 13 0.0004
645 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
646 SINUS TACHYCARDIA 5 0.0004
647 BLOOD PRESSURE ABNORMAL 7 0.0004
648 DERMATITIS CONTACT 4 0.0004
649 PARALYSIS 5 0.0003
650 CARDIAC OPERATION 3 0.0003
651 MUSCULOSKELETAL DISCOMFORT 6 0.0003
652 CARDIOGENIC SHOCK 5 0.0003
653 MUSCLE TWITCHING 8 0.0003
654 PARAESTHESIA ORAL 5 0.0003
655 INTENTIONAL SELF-INJURY 7 0.0003
656 MOOD SWINGS 11 0.0003
657 RESPIRATORY FAILURE 25 0.0003
658 BONE PAIN 20 0.0003
659 PNEUMONIA 110 0.0003
660 LABORATORY TEST ABNORMAL 10 0.0003
661 CARDIOMYOPATHY 5 0.0003
662 BONE LOSS 5 0.0003
663 HYPOAESTHESIA ORAL 5 0.0003
664 LEUKOCYTOSIS 6 0.0003
665 INSURANCE ISSUE 5 0.0003
666 MUSCLE SPASTICITY 4 0.0003
667 NERVE COMPRESSION 3 0.0003
668 COMPLETED SUICIDE 27 0.0003
669 DRUG INEFFECTIVE 426 0.0003
670 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
671 AGRANULOCYTOSIS 6 0.0003
672 ILEUS 4 0.0003
673 CARDIAC DISORDER 30 0.0003
674 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
675 DYSPNOEA EXERTIONAL 12 0.0003
676 FOOT FRACTURE 6 0.0003
677 MUSCLE ATROPHY 4 0.0003
678 ALOPECIA 62 0.0003
679 GASTRIC ULCER 6 0.0003
680 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
681 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
682 ACUTE RESPIRATORY FAILURE 6 0.0003
683 WEIGHT DECREASED 87 0.0003
684 ERECTILE DYSFUNCTION 8 0.0003
685 ROTATOR CUFF SYNDROME 4 0.0003
686 LYMPHADENOPATHY 11 0.0003
687 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
688 HAEMATOMA 8 0.0003
689 DYSSTASIA 9 0.0003
690 PARKINSONISM 3 0.0003
691 SURGERY 18 0.0003
692 OFF LABEL USE 268 0.0003
693 HEPATOMEGALY 3 0.0003
694 SHOCK 7 0.0003
695 HOSPICE CARE 3 0.0003
696 OEDEMA PERIPHERAL 37 0.0003
697 OVARIAN CYST 3 0.0003
698 MYALGIA 51 0.0003
699 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
700 FATIGUE 233 0.0003
701 MALAISE 131 0.0003
702 BLOOD UREA INCREASED 5 0.0003
703 BACK PAIN 69 0.0003
704 EYELID PTOSIS 3 0.0003
705 MOTOR DYSFUNCTION 3 0.0003
706 AKATHISIA 4 0.0003
707 ARTHRITIS 23 0.0003
708 FEELING ABNORMAL 70 0.0003
709 RESPIRATORY DISTRESS 8 0.0003
710 EYE DISCHARGE 3 0.0003
711 NERVOUS SYSTEM DISORDER 9 0.0003
712 MENTAL STATUS CHANGES 8 0.0003
713 DYSPNOEA 163 0.0003
714 NASOPHARYNGITIS 53 0.0003
715 HUNGER 4 0.0003
716 COORDINATION ABNORMAL 4 0.0003
717 SPEECH DISORDER 15 0.0003
718 EOSINOPHILIA 5 0.0003
719 PAIN IN EXTREMITY 84 0.0003
720 SKIN REACTION 4 0.0003
721 INCONTINENCE 3 0.0003
722 RETCHING 6 0.0003
723 OROPHARYNGEAL PAIN 26 0.0003
724 HEREDITARY ANGIOEDEMA 3 0.0003
725 ABNORMAL BEHAVIOUR 11 0.0003
726 GASTROENTERITIS VIRAL 5 0.0003
727 OESOPHAGITIS 3 0.0003
728 PANIC ATTACK 10 0.0003
729 APATHY 4 0.0003
730 GASTROENTERITIS 4 0.0003
731 GASTROINTESTINAL PAIN 3 0.0003
732 HYPERTENSIVE CRISIS 3 0.0003
733 HEPATIC STEATOSIS 5 0.0003
734 IMMUNODEFICIENCY 4 0.0003
735 INTESTINAL PERFORATION 3 0.0003
736 ADVERSE DRUG REACTION 24 0.0003
737 HOSPITALISATION 41 0.0003
738 ANGER 9 0.0003
739 BALANCE DISORDER 23 0.0003
740 IRRITABILITY 16 0.0003
741 CHROMATURIA 6 0.0003
742 INTESTINAL OBSTRUCTION 10 0.0003
743 DEPRESSED MOOD 14 0.0003
744 APPLICATION SITE PRURITUS 6 0.0003
745 PRODUCT AVAILABILITY ISSUE 6 0.0003
746 NEOPLASM 3 0.0003
747 JAUNDICE 7 0.0003
748 LIMB DISCOMFORT 8 0.0003
749 DYSTONIA 5 0.0003
750 LOSS OF CONSCIOUSNESS 33 0.0003
751 HAEMORRHOIDS 5 0.0003
752 PALPITATIONS 30 0.0003
753 SWOLLEN TONGUE 8 0.0003
754 RESPIRATORY ARREST 7 0.0003
755 BLOOD IRON DECREASED 3 0.0003
756 HALLUCINATION, AUDITORY 4 0.0003
757 FEELING COLD 7 0.0003
758 VISION BLURRED 34 0.0002
759 DYSKINESIA 10 0.0002
760 BONE MARROW FAILURE 5 0.0002
761 SWELLING FACE 16 0.0002
762 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
763 BRADYCARDIA 13 0.0002
764 DYSURIA 9 0.0002
765 OSTEONECROSIS 8 0.0002
766 MULTIPLE FRACTURES 4 0.0002
767 ILLNESS 25 0.0002
768 STAPHYLOCOCCAL INFECTION 8 0.0002
769 BLOOD PRESSURE INCREASED 37 0.0002
770 LIVER FUNCTION TEST ABNORMAL 7 0.0002
771 PULMONARY HYPERTENSION 5 0.0002
772 SYNCOPE 24 0.0002
773 HYPOKALAEMIA 11 0.0002
774 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
775 HEPATIC CYTOLYSIS 3 0.0002
776 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
777 EATING DISORDER 5 0.0002
778 URINARY TRACT INFECTION 40 0.0002
779 MYDRIASIS 3 0.0002
780 THERAPY CESSATION 12 0.0002
781 SCAR 4 0.0002
782 PARANOIA 4 0.0002
783 HIATUS HERNIA 3 0.0002
784 RESPIRATORY TRACT INFECTION 6 0.0002
785 DEAFNESS 6 0.0002
786 ANHEDONIA 6 0.0002
787 COVID-19 40 0.0002
788 IMMUNE SYSTEM DISORDER 3 0.0002
789 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
790 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
791 TRANSAMINASES INCREASED 5 0.0002
792 SNEEZING 5 0.0002
793 OSTEOMYELITIS 4 0.0002
794 LEUKOPENIA 11 0.0002
795 CYSTITIS 7 0.0002
796 ACUTE HEPATIC FAILURE 3 0.0002
797 CELLULITIS 11 0.0002
798 LACTIC ACIDOSIS 7 0.0002
799 POLLAKIURIA 9 0.0002
800 CHEST DISCOMFORT 22 0.0002
801 MASS 3 0.0002
802 TARDIVE DYSKINESIA 6 0.0002
803 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
804 ABDOMINAL DISTENSION 22 0.0002
805 BLOOD URINE PRESENT 4 0.0002
806 MUSCULOSKELETAL DISORDER 4 0.0002
807 FUNGAL INFECTION 7 0.0002
808 LETHARGY 12 0.0002
809 CHOLESTASIS 4 0.0002
810 SEPTIC SHOCK 9 0.0002
811 DYSPHONIA 12 0.0002
812 CHOKING 4 0.0002
813 ENCEPHALOPATHY 5 0.0002
814 RASH PRURITIC 11 0.0002
815 DYSGEUSIA 15 0.0002
816 TREATMENT NONCOMPLIANCE 11 0.0002
817 THROAT IRRITATION 9 0.0002
818 DEEP VEIN THROMBOSIS 13 0.0002
819 NEUROPATHY PERIPHERAL 19 0.0002
820 SPINAL FRACTURE 4 0.0002
821 HYPERKALAEMIA 7 0.0002
822 BLOOD POTASSIUM DECREASED 6 0.0002
823 HEPATIC FAILURE 6 0.0002
824 LACRIMATION INCREASED 6 0.0002
825 DRUG DISPENSING ERROR 3 0.0002
826 THERAPY INTERRUPTED 14 0.0002
827 BLOOD PRESSURE DECREASED 13 0.0002
828 DEVICE RELATED INFECTION 3 0.0002
829 MUSCULOSKELETAL CHEST PAIN 3 0.0002
830 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
831 INJECTION SITE REACTION 13 0.0002
832 PRODUCTIVE COUGH 9 0.0002
833 RENAL FAILURE 25 0.0002
834 NASAL CONGESTION 11 0.0002
835 IMPAIRED WORK ABILITY 4 0.0002
836 THROMBOSIS 15 0.0002
837 POOR QUALITY SLEEP 4 0.0002
838 HOT FLUSH 14 0.0002
839 THROAT TIGHTNESS 5 0.0002
840 METASTASES TO BONE 3 0.0002
841 MANIA 3 0.0002
842 MELAENA 4 0.0002
843 EMOTIONAL DISTRESS 22 0.0002
844 ANAPHYLACTIC REACTION 10 0.0002
845 RASH MACULO-PAPULAR 4 0.0002
846 NEOPLASM MALIGNANT 12 0.0002
847 DEMENTIA 5 0.0002
848 RASH PAPULAR 4 0.0002
849 COUGH 50 0.0002
850 ATRIAL FIBRILLATION 17 0.0002
851 MULTI-ORGAN FAILURE 3 0.0002
852 DEHYDRATION 23 0.0002
853 INTENTIONAL OVERDOSE 11 0.0002
854 BURNING SENSATION 12 0.0002
855 INFLUENZA 19 0.0002
856 ISCHAEMIC STROKE 3 0.0002
857 GALLBLADDER DISORDER 3 0.0002
858 CEREBRAL HAEMORRHAGE 6 0.0002
859 GOUT 3 0.0002
860 BLOOD PRESSURE FLUCTUATION 4 0.0002
861 RENAL IMPAIRMENT 14 0.0002
862 BLOOD GLUCOSE DECREASED 8 0.0002
863 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
864 HYPOGLYCAEMIA 8 0.0002
865 HYPERGLYCAEMIA 6 0.0002
866 HYPOTENSION 33 0.0002
867 END STAGE RENAL DISEASE 3 0.0002
868 ACUTE KIDNEY INJURY 25 0.0002
869 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
870 CARDIAC FAILURE 13 0.0002
871 HEART RATE INCREASED 16 0.0002
872 PSORIASIS 21 0.0002
873 MIDDLE INSOMNIA 3 0.0002
874 EPISTAXIS 12 0.0002
875 DRY EYE 8 0.0002
876 ANGIOEDEMA 7 0.0002
877 PRODUCT COMPLAINT 4 0.0002
878 CARDIOVASCULAR DISORDER 4 0.0002
879 ANAPHYLACTIC SHOCK 4 0.0002
880 SKIN ULCER 4 0.0002
881 RHINORRHOEA 10 0.0002
882 EXPOSURE VIA SKIN CONTACT 4 0.0002
883 BLOOD CREATININE INCREASED 10 0.0002
884 NERVOUSNESS 8 0.0002
885 APPLICATION SITE ERYTHEMA 4 0.0002
886 CHOLELITHIASIS 5 0.0002
887 EYE DISORDER 5 0.0002
888 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
889 VIRAL INFECTION 5 0.0002
890 EXTRA DOSE ADMINISTERED 6 0.0001
891 BODY TEMPERATURE INCREASED 3 0.0001
892 MOOD ALTERED 4 0.0001
893 MULTIPLE SCLEROSIS 7 0.0001
894 DIABETES MELLITUS 11 0.0001
895 INTENTIONAL DRUG MISUSE 3 0.0001
896 RASH MACULAR 5 0.0001
897 HEART RATE DECREASED 5 0.0001
898 RENAL FAILURE ACUTE 6 0.0001
899 RED BLOOD CELL COUNT DECREASED 4 0.0001
900 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
901 HERPES ZOSTER 8 0.0001
902 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
903 HEPATOTOXICITY 3 0.0001
904 COLITIS ULCERATIVE 6 0.0001
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
906 HEPATIC FUNCTION ABNORMAL 5 0.0001
907 PANCREATITIS ACUTE 3 0.0001
908 APHASIA 4 0.0001
909 SKIN IRRITATION 6 0.0001
910 SKIN DISCOLOURATION 6 0.0001
911 FEMUR FRACTURE 4 0.0001
912 HAEMOGLOBIN DECREASED 13 0.0001
913 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
914 PULMONARY EMBOLISM 12 0.0001
915 ABORTION SPONTANEOUS 5 0.0001
916 EXTRAPYRAMIDAL DISORDER 3 0.0001
917 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
918 VISUAL ACUITY REDUCED 4 0.0001
919 AGEUSIA 3 0.0001
920 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
921 CHRONIC KIDNEY DISEASE 9 0.0001
922 HYPOPHAGIA 3 0.0001
923 THROMBOCYTOPENIA 13 0.0001
924 ANAEMIA 22 0.0001
925 PLEURAL EFFUSION 7 0.0001
926 INCORRECT DOSE ADMINISTERED 26 0.0001
927 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
928 DRUG EFFECT INCOMPLETE 4 0.0001
929 CRYING 4 0.0001
930 INFLUENZA LIKE ILLNESS 9 0.0001
931 HAEMATOCHEZIA 6 0.0001
932 ABNORMAL DREAMS 3 0.0001
933 DIVERTICULITIS 3 0.0001
934 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
935 ARRHYTHMIA 5 0.0001
936 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
937 EYE IRRITATION 6 0.0001
938 NEEDLE ISSUE 3 0.0001
939 CORONARY ARTERY DISEASE 3 0.0001
940 FLUSHING 10 0.0001
941 SKIN BURNING SENSATION 7 0.0001
942 EMOTIONAL DISORDER 3 0.0001
943 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
944 HAEMORRHAGE 10 0.0001
945 HYPOTHYROIDISM 3 0.0001
946 METABOLIC ACIDOSIS 3 0.0001
947 HIP FRACTURE 3 0.0001
948 DISEASE PROGRESSION 11 0.0001
949 UNEVALUABLE EVENT 7 0.0001
950 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
951 VAGINAL HAEMORRHAGE 4 0.0001
952 INJECTION SITE SWELLING 7 0.0001
953 EXPIRED PRODUCT ADMINISTERED 3 0.0001
954 FLATULENCE 5 0.0001
955 GASTRIC DISORDER 3 0.0001
956 NEPHROLITHIASIS 4 0.0001
957 CARDIAC ARREST 7 0.0001
958 NO ADVERSE EVENT 15 0.0001
959 INJECTION SITE MASS 3 0.0001
960 EYE SWELLING 3 0.0001
961 PRODUCT STORAGE ERROR 7 0.0001
962 BLOOD GLUCOSE INCREASED 15 0.0001
963 COLITIS 3 0.0001
964 PRODUCT DOSE OMISSION 5 0.0001
965 ECZEMA 4 0.0001
966 DERMATITIS ATOPIC 4 0.0001
967 FEBRILE NEUTROPENIA 5 0.0001
968 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
969 DRY SKIN 10 0.0001
970 ERYTHEMA 15 0.0001
971 PANCYTOPENIA 4 0.0001
972 DEVICE MALFUNCTION 5 0.0001
973 CONVULSION 4 0.0001
974 DEVICE LEAKAGE 3 0.0001
975 INJECTION SITE PAIN 21 0.0001
976 CATARACT 4 0.0001
977 DEVICE ISSUE 6 0.0001
978 MYOCARDIAL INFARCTION 11 0.0001
979 CARDIAC FAILURE CONGESTIVE 5 0.0001
980 INJECTION SITE PRURITUS 4 0.0001
981 SKIN EXFOLIATION 5 0.0001
982 NEUTROPENIA 8 0.0001
983 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
984 HYPONATRAEMIA 3 0.0001
985 CEREBROVASCULAR ACCIDENT 9 0.0001
986 INJECTION SITE BRUISING 4 0.0001
987 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
988 DRUG DOSE OMISSION 7 0.0000
989 INJECTION SITE ERYTHEMA 5 0.0000
990 PLATELET COUNT DECREASED 4 0.0000